Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

MarketBeat

Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure

Align Technology (NASDAQ:ALGN) CFO John Morici said the company continues to navigate a challenging but stable demand environment, with international markets and dental service organizations offsetting pressure in parts of North America. Speaking at the Jefferies Global Healthcare Conference in a f

MarketBeat

U.S Stock Market on Friday: S&P 500, Dow Jones, Nasdaq, Russell 2000 investors eye May jobs report. Check VIX volatility index, list of key Wall Street factors

U.S Stock Market investors will keep an eye on the latest jobs report. It will indicate the health of the economy amid fears of rising inflation.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

ServiceTitan Q1 Earnings Call Highlights

ServiceTitan (NASDAQ:TTAN) reported 25% year-over-year revenue growth for its fiscal first quarter of 2027, as executives said the company benefited from healthy demand across residential and commercial trades, stronger gross transaction volume and early traction for its AI-focused Max offering. Co

MarketBeat

Docusign Q1 Earnings Call Highlights

Docusign (NASDAQ:DOCU) reported 9% year-over-year revenue growth in the first quarter of fiscal 2027 and said adoption of its AI-native Intelligent Agreement Management platform, or IAM, continued to expand across its customer base. CEO Allan Thygesen said on the company’s earnings call that Docusi

MarketBeat

Zumiez Q1 Earnings Call Highlights

Zumiez (NASDAQ:ZUMZ) reported higher first-quarter sales and improved margins for fiscal 2026, but executives said consumer discretionary spending pressure intensified late in the quarter and continued into May, prompting a cautious outlook for the second quarter. Chief Executive Officer Rick Brook

MarketBeat

lululemon athletica Q1 Earnings Call Highlights

lululemon athletica (NASDAQ:LULU) reported modest first-quarter revenue growth but lowered its fiscal 2026 outlook, citing softer recent sales trends, negative media and social commentary around the brand, and product launches that did not meet expectations. Meghan Frank, interim co-CEO and chief f

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Stocks Rebound on Strength in Banks and Managed Healthcare

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.41%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +1.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.53%. June E-mini S&P futures (ESM26 ) rose +0.36%, and June E-mini Nasdaq futures...

Barchart

The Dow leaps to a record as oil prices ease and US stocks outside of AI rally

Wall Street rallied after falling oil prices and yields in the bond market eased the pressure on U.S. stocks

AAP

US stocks today: Dow soars 800 points to hit record as Iran optimism offsets chip slump, weak jobs data

Wall Street closed higher with the Dow hitting a record, lifted by easing Iran war concerns and gains in healthcare and financial stocks. However, weak results from Broadcom dragged chipmakers, capping Nasdaq gains. Rising jobless claims and AI-driven layoffs added to uncertainty around economic strength and market valuations.

The Economic Times

The Dow jumps 875 points as oil prices ease and stocks outside of AI rally

Wall Street rallied after falling oil prices and yields in the bond market eased the pressure on U.S. stocks

AAP

Honeywell's Quantinuum valued at $17.6 billion as shares rise in Nasdaq debut

Quantinuum shares jump 13.3% in their Nasdaq debut, valuing the Honeywell-backed quantum firm at $17.6 billion. Strong investor interest reflects optimism around quantum computing’s long-term potential, despite limited revenues and ongoing losses. The company raised $1.68 billion, though adoption challenges and revenue concentration remain key concerns for investors.

The Economic Times

Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052

Aclaris Therapeutics (NASDAQ:ACRS) executives outlined a busy clinical calendar for the biotechnology company during a fireside chat at the Jefferies 2026 Global Healthcare Conference, highlighting upcoming readouts across its immunology pipeline and a planned Phase 2 asthma study for its lead bispe

MarketBeat

SpaceX and Anthropic are about to go public—and your 401(k) may be forced to buy in

The dot-com guardrails are being dismantled just as SpaceX and Anthropic go public, experts warn. Your retirement account could feel it.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

X-Energy Q1 Earnings Call Highlights

X-Energy (NASDAQ:XE) used its first earnings call as a public company to outline progress on its advanced nuclear reactor and fuel businesses, while reporting higher first-quarter revenue and grant income tied to its federal cost-share program. The company began trading on the Nasdaq on April 24 an

MarketBeat

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Rocket Lab's 18% pullback from its 52-week high appears to reflect normal consolidation rather than any deterioration in business fundamentals.

Barchart

Stocks Mixed as Tech Weakness Weighs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.90%. June E-mini S&P futures (ESM26 ) are up +0.02%, and June E-mini Nasdaq futures...

MarketBeat

Before the IPO: 4 Companies That Rewarded Investors Who Got In Early

Weiss Ratings analyst Chris Graebe outlines how Regulation A offerings let retail investors access private companies like FJET, NUCL, and CNXU before their public listings.

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks.

Barchart

Weakness in Technology Stocks Pressures Stock Indexes

The S&P 500 Index ($SPX ) (SPY ) today is down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.23%. June E-mini S&P futures (ESM26 ) are down -0.14%, and June E-mini Nasdaq futures...

AAP

Slumping AI stocks weigh on Wall Street, even as oil price ease

AI winners are giving back some of their big recent runs, leaving the U.S. market mixed as oil prices ease

The Economic Times

US stocks today: Nasdaq nosedives as Broadcom revenue miss dents chip stocks

The S&P 500 and the Nasdaq dropped at the open on Thursday, as ‌Broadcom's ⁠revenue ⁠miss pressured chip stocks, while equity investors took a breather after a strong rally to ⁠record highs.

AAP

Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $437 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Over 283 Million WLD Tokens

EASTON, Pa., June 4, 2026 /PRNewswire/ -- Eightco Holdings Inc. (NASDAQ: ORBS) ("Eightco" or the "Company") today provided an update on its total holdings, highlighting its growing position across digital assets and strategic investments in leading private technology companies.

MarketBeat

Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach

Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to invest in its pipeline and positioning the business for sustainable profitability. Chief Financia

Barchart

Is Alphabet Stock Underperforming the Nasdaq?

Alphabet has lagged the Nasdaq recently, but analysts still see plenty of room for growth ahead.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.